DocDollars

Ionis Pharmaceuticals, Inc.

CA · United States · Reporting entity ID 100001453731

Total reported 2019–2025
$23.3M
#289 of 2,960 reporting companies — 0% of all reported industry payments
$3.29M in general payments across 5,570 records, plus $20.0M in research funding across 2,645 records.

How it breaks down

General payments $3,288,489
Research funding $20,011,333

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ionis Pharmaceuticals, Inc. reported $23.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #289 of 2,960 reporting companies. 86% of that was research funding and 14% general payments such as consulting, speaking, food and travel. 5,570 general payment records and 2,645 research records were filed.

Common questions about Ionis Pharmaceuticals, Inc.

How much has Ionis Pharmaceuticals, Inc. paid US doctors?

Ionis Pharmaceuticals, Inc. reported $23,299,822 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,288,489 in general payments, $20,011,333 in research funding.

How does Ionis Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #289 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ionis Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.